IRIS
GUIDOTTI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 829
NA - Nord America 575
AS - Asia 261
OC - Oceania 4
Totale 1.669
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 574
SE - Svezia 528
SG - Singapore 178
RU - Federazione Russa 123
IT - Italia 93
CN - Cina 59
FI - Finlandia 27
DE - Germania 26
IE - Irlanda 16
IN - India 8
ID - Indonesia 5
AU - Australia 4
GB - Regno Unito 4
IR - Iran 4
FR - Francia 3
RO - Romania 3
TW - Taiwan 3
CH - Svizzera 2
AT - Austria 1
JP - Giappone 1
KN - Saint Kitts e Nevis 1
KR - Corea 1
MK - Macedonia 1
NL - Olanda 1
PH - Filippine 1
PK - Pakistan 1
UA - Ucraina 1
Totale 1.669
Salva come PNG Salva come JPEG
Città #
Lawrence 142
Princeton 142
Ashburn 118
Singapore 97
Milan 43
Shanghai 30
Boardman 29
Helsinki 27
Moscow 17
Dublin 16
New York 16
Pune 8
Rome 6
Los Angeles 5
Ancona 4
Bloomington 4
Dallas 4
San Giustino Valdarno 4
Bandung 3
Flero 3
Saint-Martin-d'Hères 3
Vernate 3
Washington 3
Zhengzhou 3
Arezzo 2
Brisbane 2
Cernusco sul Naviglio 2
Chandler 2
Clusone 2
Freiburg im Breisgau 2
Genoa 2
Haining 2
Hanover 2
Mainz 2
Padang 2
Seattle 2
Taipei 2
Turin 2
Xiamen 2
Amsterdam 1
Andover 1
Borås 1
Buffalo 1
Chiaravalle 1
Chiari 1
Cornate 1
Davao City 1
Frankfurt am Main 1
Gorle 1
Guangzhou 1
Hillsboro 1
Jiaxing 1
Liberty Lake 1
London 1
Lucca 1
Monza 1
Nagoya 1
Newcastle 1
Quanzhou 1
San Francisco 1
Santa Clara 1
Segrate 1
Seoul 1
Shenyang 1
Skopje 1
Sydney 1
Vienna 1
Walsall 1
Wuhan 1
Wuxi 1
Zola Predosa 1
Totale 792
Salva come PNG Salva come JPEG
Nome #
Role of CCL2/MCP-1 in islet transplantation 39
Immunobiology and pathogenesis of hepatitis B virus infection 39
Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming 31
Cyclic inhibitors of hepatitis B virus 25
Inflammatory monocytes hinder antiviral B cell responses 24
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models 23
Immunosurveillance of the liver by intravascular effector CD8+ T cells 21
Extracellular HBsAg clearance has minimal impact on CD8+ T cell responses in mouse models of HBV pathogenesis 21
Inhibitors of hepatitis B virus 21
Preclinical assessment of capsid assembly modulators (CAMs) of varying potency revealed a novel class of picomolar-acting CAMs inducing neither significant HBcAg cytoplasmic retention nor adverse interactions with HBcAg-specific adaptive immunity 20
Group 1 ILCs regulate T cell-mediated liver immunopathology by controlling local IL-2 availability 20
Pathogen-specific B-cell receptors drive chronic lymphocytic leukemia by light-chain-dependent cross-reaction with autoantigens 19
Anti-platelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma 19
Bisphosphonates Target B Cells to Enhance Humoral Immune Responses 19
Arenaviral infection causes bleeding in mice due to reduced serotonin release from platelets 18
Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B. 18
Antiplatelet drug therapy moderates immune-mediated liver disease and inhibits viral clearance in mice infected with a replication-deficient adenovirus 18
Kupffer cells hasten resolution of liver immunopathology in mouse models of viral hepatitis 18
Identification of a Kupffer cell subset capable of reverting the T cell dysfunction induced by hepatocellular priming 18
Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion 18
Tricyclic inhibitors of hepatitis B virus 18
Discovery and antiviral profile of new sulfamoylbenzamide derivatives as HBV capsid assembly modulators 17
Bone marrow as an alternative site for islet transplantation 17
Bone marrow as an alternative site for islet transplantation 17
Modulation of Early Inflammatory Reactions to Promote Engraftment and Function of Transplanted Pancreatic Islets in Autoimmune Diabetes 17
Breaking tolerance leads to autoantibody production but not autoimmune liver-disease in hepatitis-B virus envelope transgenic mice 16
Editorial overview: Viral pathogenesis 16
IFN gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment 16
A global scientific strategy to cure hepatitis B 16
Serum HBsAg clearance has minimal impact on CD8+ T cell responses in mouse models of HBV infection 16
Continuous sensing of IFNα by hepatic endothelial cells shapes a vascular antimetastatic barrier 15
T helper-1 lymphocytes mediate liver disease in hepatitis B virus transgenic mice 15
Kupffer cells reduce liver immunopathology 15
Protective and Pathogenic T Cell Responses to Virus Infections 15
Oxalamido-substituted tricyclic inhibitors of hepatitis B virus 15
Immunological insights in the treatment of chronic hepatitis B 15
A two hit model of CTL killing in vivo 14
Cytotoxic T-lymphocytes inhibit hepatitis-B virus gene-expression by a noncytolytic mechanism in transgenic mice 14
Altered helper T lymphocyte (HTL) function associated with chronic HBV infection and its role in response to therapeutic vaccination in humans 14
The COP9 signalosome is a repressor of replicative stress responses and polyploidization in the regenerating liver 14
Platelets mediate cytotoxic T lymphocyte-induced liver damage 14
Naive HIV/HCV-coinfected patients have higher intrahepatic pro-inflammatory cytokines than coinfected patients treated with antiretroviral therapy 13
HBV pathogenesis in animal models: Recent advances on the role of platelets 13
MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs 13
Platelets mediate CTL-induced immunopathology in the liver 13
Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice 13
Cytokine-mediated control of viral infections 13
Cytotoxic T-lymphocytes can clear hepatitis-B virus from the hepatocyte without killing the cell 13
Activated intrahepatic antigen presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice 13
Effector CD8 T cell trafficking within the liver 13
Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans 13
Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes 13
HBV Immunopathogenesis 13
Cytotoxic T-lymphocyte mediated regulation of hepatitis-B virus gene-expression in-vivo 12
Pathogenesis of hepatitis B virus in transgenic mice 12
Characterization of nuclear RNases that cleave hepatitis B virus RNA near the La protein binding site 12
Platelets mediate clearance of lymphocytic choriomeningitis virus infection preventing lethal hemorrhage 12
A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen 12
Effector CD8+T cell-derived interleukin-10 enhances acute liver immunopathology 12
Host-virus interactions during malaria infection in hepatitis B virus transgenic mice 12
Microcirculation in the murine liver: a computational fluid dynamic model based on 3D reconstruction from in vivo microscopy 12
Update of the statements on biology and clinical impact of occult hepatitis B virus infection 12
Class-I restricted cytotoxic T-lymphocytes are directly cytopathic for their target-cells in-vivo 12
Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice 11
Different intrahepatic cytoknie priles during acure HBV and HCV infection in the same chimpanzees 11
Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes 11
The optimization of helper T lymphocyte (HTL) function in vaccine development 11
On the role of platelets in the pathogenesis of viral hepatitis 11
CTL access to tissue antigen is restricted in-vivo 11
Mechanisms of class-I restricted immunopathology - a transgenic mouse model of fulminant-hepatitis 11
In vivo flow mapping in complex vessel networks by single image correlation 11
Platelets mediate cytotoxic T lymphocyte-induced liver damage 11
Eukaryotic translation initiation factor 6 is a novel regulator of reactive oxygen species-dependent megakaryocyte maturation 11
Hepatitis B virus RNA-binding proteins associated with cytokine-induced clearance of viral RNA from the liver of transgenic mice 11
Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination 11
Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus 10
Platelets prevent IFN-alpha/beta-induced lethal hemorrhage promoting CTL-dependent clearance of lymphocytic choriomeningitis virus 10
Nkx2-5+/Islet1+ mesenchymal progenitors generate distinct spleen stromal cell subsets and participate in restoring stromal network integrity 10
Hepatitis-B virus nucleocapsid particles do not cross the hepatocyte nuclear-membrane in transgenic mice 10
Interleukin-2 down-regulates hepatitis-B virus gene-expression in transgenic mice by a posttranscriptional mechanism 10
Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes 10
Differential induction of carcinogen metabolizing enzymes in a transgenic mouse model of fulminant hepatitis 10
Reduced severity of liver ischemia/reperfusion injury following hepatic resection in humans is associated with enhanced intrahepatic expression of Th2 cytokines 10
Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice 10
Hepatitis B virus (HBV) precore protein inhibits HBV replication in transgenic mice 10
The hepatitis B virus X protein transactivates viral core gene expression in vivo 10
Natural killer T cell activation inhibits hepatitis B virus replication in vivo 10
The transgenic mouse model of hepatitis B virus infection 10
Mouse models of hepatitis B virus pathogenesis 10
Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study 10
Nirmatrelvir treatment of SARS-CoV-2-infected mice blunts antiviral adaptive immune responses 9
Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis 9
Liver gene expression associated with the inhibition of HBV replication or transcription 9
High-level hepatitis-B virus-replication in transgenic mice 9
To kill or to cure: Options in host defense against viral infection 9
Pathogenetic and antiviral immune responses against hepatitis B virus 9
Depletion of neutrophils blocks the recruitment of antigen-nonspecific cells into the liver without affecting the antiviral activity of hepatitis B virus-specific cytotoxic T lymphocytes 9
Immune pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice 9
Cutting edge: Inhibition of hepatitis B virus replication by activated NK T cells does not require inflammatory cell recruitment to the liver 9
Hepatitis C virus core and E2 protein expression in transgenic mice 9
Totale 1.423
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.276
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.276
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 2 1 1 0 0 0 0 0 0
2020/202116 0 1 0 3 2 3 5 0 0 2 0 0
2021/2022121 0 0 0 57 2 0 6 3 5 7 5 36
2022/2023846 302 200 62 2 13 118 21 78 31 1 4 14
2023/2024419 22 16 59 114 29 37 13 29 4 10 31 55
2024/2025284 264 20 0 0 0 0 0 0 0 0 0 0
Totale 1.776